Cronos Group Inc. CRON
We take great care to ensure that the data presented and summarized in this overview for Cronos Group Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding CRON
View all-
Chescapmanager LLC Baltimore, MD8.33MShares$19.4 Million2.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.09MShares$16.5 Million0.0% of portfolio
-
Toroso Investments, LLC Massapequa, NY6.6MShares$15.4 Million0.31% of portfolio
-
ETF Managers Group, LLC Summit, NJ5.53MShares$12.9 Million0.39% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.12MShares$7.28 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.44MShares$5.68 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.55MShares$3.62 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.15MShares$2.68 Million0.0% of portfolio
-
Mirae Asset Global Investments Co., Ltd.1MShares$2.34 Million0.0% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD803KShares$1.87 Million0.36% of portfolio
Latest Institutional Activity in CRON
Top Purchases
Top Sells
About CRON
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Insider Transactions at CRON
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2024
|
Arye Weigensberg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,972
+5.74%
|
-
|
|
May 25
2024
|
Adam Wagner SVP, Head of Cronos Israel |
BUY
Exercise of conversion of derivative security
|
Direct |
2,692
+8.06%
|
-
|
|
May 12
2024
|
Terrence Gregory Joseph Doucet Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,492
-14.69%
|
$19,476
$3.8 P/Share
|
|
May 12
2024
|
Terrence Gregory Joseph Doucet Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,876
+22.56%
|
-
|
|
May 12
2024
|
Adam Wagner SVP, Head of Cronos Israel |
BUY
Exercise of conversion of derivative security
|
Direct |
6,276
+18.31%
|
-
|
|
May 12
2024
|
Arye Weigensberg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,014
+12.83%
|
-
|
|
May 10
2024
|
Terrence Gregory Joseph Doucet Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.55%
|
$1,476
$3.9 P/Share
|
|
May 10
2024
|
Terrence Gregory Joseph Doucet Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,560
+4.67%
|
-
|
|
May 10
2024
|
Adam Wagner SVP, Head of Cronos Israel |
BUY
Exercise of conversion of derivative security
|
Direct |
10,064
+31.66%
|
-
|
|
Mar 15
2024
|
Arye Weigensberg Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,237
+31.7%
|
-
|
|
Mar 15
2024
|
James Holm Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
30,947
-32.0%
|
$30,947
$1.98 P/Share
|
|
Mar 15
2024
|
James Holm Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
96,724
+50.0%
|
-
|
|
Mar 15
2024
|
Jeffrey David Jacobson Chief Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,126
-6.78%
|
$36,126
$1.98 P/Share
|
|
Mar 15
2024
|
Jeffrey David Jacobson Chief Growth Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
90,958
+14.49%
|
-
|
|
Mar 15
2024
|
Anna Shlimak Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,694
-6.21%
|
$20,694
$1.98 P/Share
|
|
Mar 15
2024
|
Anna Shlimak Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
75,226
+18.29%
|
-
|
|
Mar 15
2024
|
Shannon Buggy SVP, Global Head of People |
SELL
Payment of exercise price or tax liability
|
Direct |
12,932
-8.65%
|
$12,932
$1.98 P/Share
|
|
Mar 15
2024
|
Shannon Buggy SVP, Global Head of People |
BUY
Exercise of conversion of derivative security
|
Direct |
34,827
+18.86%
|
-
|
|
Mar 15
2024
|
Michael Ryan Gorenstein Director |
SELL
Payment of exercise price or tax liability
|
Direct |
86,661
-0.43%
|
$86,661
$1.98 P/Share
|
|
Mar 15
2024
|
Michael Ryan Gorenstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
355,900
+1.7%
|
-
|
Last 12 Months Summary
| Exercise of conversion of derivative security | 1.1M shares |
|---|
| Payment of exercise price or tax liability | 302K shares |
|---|